Moreover, quite a few effectively established adverse prognostic markers, which include U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their destructive result in patients dealt with with VO. The only component that remained predictive of a shorter progression-free survival In this part